To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

NCT05410535 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

431

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Patients who continued UDCA 300mg medication
OTHER: Patients who discontinued UDCA 300mg prescription

Sponsor

Daewoong Pharmaceutical Co. LTD.